Curebase
Delivers software and clinical services to power decentralized and hybrid clinical trials.
What they do
Curebase offers a decentralised clinical trial platform combined with virtual site services. Their software enables researchers to conduct studies at any clinic or patient home, offering tools for remote consent, electronic data capture, and virtual investigator visits.
The record
- Vertical
- Clinical Trials
- Sub-segment
- Decentralised trials
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- San Francisco, USA
- Region
- North America
- Founded
- 2017
- Total funding
- $40M raised
Notable investors: GGV Capital, Bold Capital Partners, Y Combinator, General Catalyst.